Metropolis Healthcare Ltd

₹ 1,437 -0.55%
07 Dec - close price
About

Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services.

  • Market Cap 7,359 Cr.
  • Current Price 1,437
  • High / Low 3,580 / 1,318
  • Stock P/E 47.6
  • Book Value 187
  • Dividend Yield 0.56 %
  • ROCE 29.0 %
  • ROE 25.4 %
  • Face Value 2.00

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 28.1%
  • Company has been maintaining a healthy dividend payout of 24.4%

Cons

  • Stock is trading at 7.69 times its book value
  • Promoter holding has decreased over last 3 years: -7.64%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
223 223 207 143 288 275 292 327 303 293 306 280 300
161 159 156 131 197 188 195 224 212 218 231 211 221
Operating Profit 62 64 51 12 91 87 96 102 90 75 75 68 79
OPM % 28% 29% 25% 8% 32% 32% 33% 31% 30% 26% 24% 24% 26%
2 2 -15 3 3 4 2 20 6 3 6 3 4
Interest 2 2 2 2 2 2 3 6 3 5 6 8 7
Depreciation 9 11 11 10 11 11 14 13 15 17 18 21 22
Profit before tax 53 53 23 4 81 78 82 103 78 56 56 43 55
Tax % 19% 20% 34% 18% 26% 25% 25% 27% 25% 27% 29% 22% 26%
Net Profit 43 42 15 3 61 59 61 75 58 41 40 34 40
EPS in Rs 8.57 8.38 3.06 0.57 11.84 11.46 12.00 14.65 11.39 8.02 7.81 6.53 7.88
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
388 456 475 545 647 761 856 998 1,228 1,179
285 339 359 405 467 559 619 708 880 881
Operating Profit 104 117 116 140 181 203 237 290 348 298
OPM % 27% 26% 24% 26% 28% 27% 28% 29% 28% 25%
10 7 29 39 6 8 -17 12 34 16
Interest 3 2 2 2 4 4 13 12 25 26
Depreciation 16 21 17 17 19 20 39 46 63 78
Profit before tax 95 101 128 160 164 187 169 244 293 210
Tax % 34% 33% 36% 33% 32% 34% 24% 25% 27%
Net Profit 63 68 82 107 112 124 128 183 215 155
EPS in Rs 57.34 61.82 80.47 106.52 109.23 23.94 25.15 35.82 41.85 30.24
Dividend Payout % 2% 0% 100% 49% 0% 55% 32% 22% 19%
Compounded Sales Growth
10 Years: %
5 Years: 18%
3 Years: 17%
TTM: -1%
Compounded Profit Growth
10 Years: %
5 Years: 17%
3 Years: 20%
TTM: -36%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 2%
1 Year: -55%
Return on Equity
10 Years: %
5 Years: 28%
3 Years: 28%
Last Year: 25%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
10 10 10 10 10 10 10 10 10 10
Reserves 292 352 269 314 405 408 513 696 876 946
20 14 5 1 1 18 67 112 379 305
69 87 107 188 110 113 160 181 256 245
Total Liabilities 391 462 391 512 526 550 750 1,000 1,521 1,507
149 153 142 202 207 213 296 343 1,059 1,119
CWIP 1 0 1 1 0 6 3 0 6 0
Investments 132 168 101 142 102 33 14 10 16 29
109 141 147 167 216 298 437 647 440 360
Total Assets 391 462 391 512 526 550 750 1,000 1,521 1,507

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
77 69 91 102 104 90 215 249 253
-61 -56 96 -86 1 36 -104 63 -736
-14 -9 -174 -17 -87 -118 -55 -33 163
Net Cash Flow 2 4 14 -1 18 8 56 279 -321

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 47 57 54 54 57 66 55 45 40
Inventory Days 47 52 46 38 53 55 44 59 68
Days Payable 75 92 96 97 88 90 152 160 136
Cash Conversion Cycle 19 17 3 -5 21 30 -54 -56 -29
Working Capital Days 22 32 8 -27 28 42 11 4 14
ROCE % 29% 36% 49% 45% 44% 40% 36% 29%

Shareholding Pattern

Numbers in percentages

6 recently
Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
57.41 56.90 50.81 50.57 50.39 50.38 50.37 50.33 49.50 49.79 49.79 49.76
16.58 16.14 25.31 25.44 27.20 27.24 28.59 30.72 30.06 21.91 23.20 25.57
5.93 6.10 14.28 16.69 14.63 15.73 14.59 12.26 11.35 16.20 14.50 12.38
20.08 20.86 9.60 7.30 7.78 6.65 6.45 6.69 9.09 12.11 12.52 12.30

* The XBRL reporting format changed from Sep'2022 onwards. The new format added details about banks and foreign portfolio investors. These were not available earlier.
The sudden increase in FII or DII might be because of these changes.

Please click on the line-items to see the names of individual entities.

Documents

Concalls